Recent perspectives in clinical development of malaria vaccines
Malaria vaccine research has progressed significantly, with RTS,S/AS01 and R21/Matrix-M receiving WHO endorsement in 2021 / 2023. These vaccines show promise, but challenges like vaccine adherence, strain variation, and resistance persist, highlighting the need for more effective, broad-reaching int...
Saved in:
| Main Authors: | Jack Feehan, Magdalena Plebanski, Vasso Apostolopoulos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-58963-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Malaria vaccine a boon to Endemic regions - Doubling efficacy rates, at lower cost
by: Amrit Kahlon, et al.
Published: (2024-11-01) -
Inflammation: The Cause of All Diseases
by: Vivek P. Chavda, et al.
Published: (2024-11-01) -
Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.
by: Stephen M Todryk, et al.
Published: (2008-04-01) -
Recent Advances in the Treatment of Malaria
by: Jawaher M. Alghamdi, et al.
Published: (2024-11-01) -
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
by: Ren-You Pan, et al.
Published: (2018-01-01)